机器人胃癌根治术与腹腔镜胃癌根治术长期肿瘤学结局的Meta分析
该Meta分析比较机器人胃切除术(RG)与腹腔镜胃切除术(LG)治疗胃癌的长期肿瘤学结局。纳入5项回顾性设计或前瞻性数据收集研究、共1614例患者,汇总分析显示两组总生存期(OS)、无病生存期(DFS)及复发率均无显著差异。结论认为RG可提供与LG相当的长期肿瘤学结局,但仍需更多随机临床试验和更大样本更长随访验证。
要点
- RG与LG在OS、DFS和复发率上均无显著差异。
- 纳入5项研究共1614例胃癌患者,随访时间较长。
- 仍需随机临床试验和更长随访进一步证实RG价值。
核心结论
- RG治疗胃癌的长期肿瘤学结局(OS、DFS、复发率)与LG相当。
研究设计与样本
- Meta分析,检索多个数据库至2017年2月,纳入5项回顾性设计或前瞻性数据收集研究,共1614例胃癌患者。
主要发现
- 5项研究均评估OS,2项评估DFS,4项报告复发率或复发例数。
- 汇总分析显示RG与LG的OS和DFS无显著差异,且无显著研究间异质性。
- RG与LG的复发率无显著差异,无显著异质性。
临床怎么用
- 对于胃癌患者,RG可作为与LG相当的长期肿瘤学结局选择。
局限性
- 纳入研究为回顾性设计或前瞻性数据收集,非随机对照试验。
- 仍需更多随机临床试验和更大样本、更长随访进一步证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic gastrectomy (RG) has been a new technical alternative for gastric cancer. However, the long-term oncological outcomes of RG still should be further evaluated. In this meta-analysis, the long-term oncological outcomes of RG and laparoscopic gastrectomy (LG) are compared. METHODS: Comprehensive searches from various databases are compared in February 2017 to identify that the oncological outcomes of RG and LG are evaluated in gastric cancer patients. The pooled oncological outcomes of the overall survival (OS), disease-free survival (DFS), and the recurrence rate were performed by adopting the meta-analysis to calculate the hazard ratio (HR) or the odds ratio with 95% confidence intervals (CIs). RESULTS: Five studies that concern retrospective design and prospective data collection and involve 1614 patients were included. All the five studies evaluated OS. Two studies evaluated DFS, while four studies reported the recurrence rate or recurrence cases in RG and LG groups with the long-term follow-up. The pooled analysis showed no significant difference in OS and DFS between RG and LG, without significant between-study heterogeneity. Besides, the recurrence rate between RG and LG had no significant difference without heterogeneity. CONCLUSIONS: RG could provide comparable long-term oncological outcomes as well as LG for the treatment of gastric cancer. OS, DFS, and the recurrence rate by the long-time follow-up of RG were comparable with LG. Generally speaking, more randomized clinical trials and a larger patient cohort with longer follow-up are still essential to further demonstrate the value of the robotic surgery for gastric cancer.
引用
- Pan JH, Zhou H, Zhao XX, et al. Long-term oncological outcomes in robotic gastrectomy versus laparoscopic gastrectomy for gastric cancer: a meta-analysis. Surg Endosc. 2017. PMID: 28963583. doi:10.1007/s00464-017-5891-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。